FDA Inspection 842545 — GlaxoSmithKline Manufacturing S.p.A.

GlaxoSmithKline Manufacturing S.p.A. — FEI 3002807114

The FDA completed an inspection of GlaxoSmithKline Manufacturing S.p.A. on July 10, 2013 in Torrile. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 10, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrile (Italy)